HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of
International Ophthalmology Conference
March 10-12, 2025 | Rome, Italy
Patient Education, Patient Compliance, Patient Adherence/Satisfaction
Patient Education, Patient Compliance, Patient Adherence/Satisfaction
Patient education is the process of providing information to patients and their careers that will help them change their health behaviors or improve their health condition. Physicians must increase patients' health literacy in order to promote patient education and engagement. The ability to seek, understand, and act on health information is characterized as health literacy. Adherence is defined as the patient's "active, voluntary, and collaborative participation in a mutually acceptable course of conduct to achieve a therapeutic result." Choice and mutuality in goal formulation, treatment planning, and regimen administration are implicit in the concept of adherence.
Committee Members
John David Bullock
Wright State University, United States
Edward Charles Kondrot
Healing the Eye Wellness Center, United States
Minckler Don S
UCI Gavin Herbert Eye Institute, United States IOC 2025 Speakers
Dhruva Drew Gupta
Harvard Medical School, United States
Nour Abou Shousha
Harvard Medical School, United States
George HH Beiko
McMaster Univeresity, Canada
Mustafa Al Ghazi
University Hospital of Wales, United KingdomSubmit your abstract Today
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI Gavin Herbert Eye Institute, United States
Title : Eyes and guts connection: Microbiomes and their role in ocular health
Edward Charles Kondrot, Healing the Eye Wellness Center, United States
Title : Why was Leonhard Euler blind?
John David Bullock, Wright State University, United States
Title : Ultra-widefield protocol enhances automated classification of diabetic retinopathy severity with OCT angiography
Kasra Rezaei, University of Washington, United States
Title : A factorial randomized controlled trial of tissue plasminogen activator and/or perfluoropropane for the treatment of submacular hemorrhage secondary to neovascular age-related macular degeneration (TAPAS)
Tim Jackson, King’s College London, United Kingdom
Title : Developing resilience-based treatments for glaucoma
Simon John, Columbia University, United States